celzwelling

Celzwelling, or cell swelling, is a process in which individual cells increase their volume due to the influx of water, typically as a result of cellular injury or metabolic disturbance. It is a central feature of cytotoxic edema and is commonly observed in the early stages of ischemic or hypoxic injury, as well as in certain toxin- or electrolyte-related states. The phenomenon can affect many cell types, including neurons and glial cells in the brain, hepatocytes, and other tissues.

Mechanism-wise, normal cells maintain ion gradients with energy-dependent pumps such as the Na+/K+-ATPase. When energy production fails, these pumps falter, causing Na+ to accumulate inside the cell. Water follows osmotically, leading to swelling of the cytoplasm and organelles, especially mitochondria and the endoplasmic reticulum. If energy supply is not restored, membrane integrity may be compromised and cells can progress to dysfunction or death. The swelling is often reversible in the early phase if homeostasis is re-established, but prolonged swelling can cause substantial cellular injury and s a rise in pressure in confined compartments, notably in brain tissue.

Celzwelling can result from ischemia, hypoxia, severe electrolyte disturbances, toxins, and inflammatory mediators. In the brain, it is often discussed in relation to cytotoxic edema versus vasogenic edema: cytotoxic edema reflects intracellular water accumulation due to cell injury, whereas vasogenic edema involves extracellular fluid accumulation from blood–brain barrier disruption.

Diagnosis is typically clinical and, in imaging or research contexts, may show signs consistent with cytotoxic edema such as restricted diffusion on diffusion-weighted MRI. Treatment centers on addressing the underlying cause, restoring perfusion and oxygenation, and managing complications, including stabilization of electrolytes and, when indicated, measures to reduce intracranial pressure.